Work productivity loss with depression, diagnosed and undiagnosed, among workers in an internet-based survey conducted in Japan

Journal of Occupational and Environmental Medicine

Volumn 57, Issue 1, 2015, Pages 105-110

  Asami, Yuko ^a   Goren, Amir ^b   Okumura, Yasuyuki ^c  

^a PFIZER INC   (United States)

^b KANTAR HEALTH   (United States)

^c 11 Toyo Kaiji Bldg   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; INTERNET; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT HEALTH QUESTIONNAIRE 9; PRODUCTIVITY; WORK CAPACITY; WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE; WORKPLACE; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

ABSENTEEISM; ADULT; CROSS-SECTIONAL STUDIES; DEPRESSION; EFFICIENCY; FEMALE; HEALTH SURVEYS; HUMANS; INTERNET; JAPAN; MALE; MIDDLE AGED; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84921474291     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000310     Document Type: Article

References (22)

1. World Health Organization. Depression. WHO; 2012.
2. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119-138.
3. IsHak WW, Greenberg JM, Balayan K, et al. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry. 2011;19:229-239.
4. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
5. Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res. 2003;12: 3-21.
6. Kawakami N, Takeshima T, Ono Y, et al. Twelve month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002-2003. Psychiatr Clin Neurosci. 2005;59:441-452.
7. Ministry of Health Labour and Welfare of Japan. Patient Survey in 2011 (Kanja Chosa). Edited by Ministry of Health Labour and Welfare of Japan. Tokyo: Ministry of Health Labour and Welfare of Japan (in Japanese); 2012.
8. Donohue JM, Pincus HA. Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment. Pharmacoeconomics. 2007;25:7-24.
9. Okumura Y, Higuchi T. Cost of depression among adults in Japan. Prim Care Companion CNS Disord. 2011;13(3).
10. Wada K, Arakida M, Watanabe R, Negishi M, Sato J, Tsutsumi A. The economic impact of loss of performance due to absenteeism and presenteeism caused by depressive symptoms and comorbid health conditions among japanese workers. Ind Health. 2013;51:482-489.
11. Wang PS, Aguilar-Gaxiola S, Alonso J, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in theWHO world mental health surveys. Lancet. 2007;370:841-850.
12. Naganuma Y, Tachimori H, Kawakami N, et al. Twelve-month use of mental health services in four areas in Japan: findings from theWorld Mental Health Japan Survey 2002-2003. Psychiatry Clin Neurosci. 2006;60:240-248.
13. Kido Y, Kawakami N. Sociodemographic determinants of attitudinal barriers in the use of mental health services in Japan: findings from theWorld Mental Health Japan Survey 2002-2006. Psychiatry Clin Neurosci. 2013;67:101-109.
14. Tsuchiya M, Kawakami N, Ono Y, et al. Impact of mental disorders on work performance in a community sample of workers in Japan: the World Mental Health Japan Survey 2002-2005. Psychiatry Res. 2012;198:140-145.
15. Ryder AG, Yang J, Zhu X, et al. The cultural shaping of depression: somatic symptoms in China, psychological symptoms in North America? J Abnorm Psychol. 2008;117:300-313.
16. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002;32:509-521.
17. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQprimary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282:1737-1744.
18. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353-365.
19. Muramatsu K, Miyaoka H, Kamijima K, et al. The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep. 2007;101:952-960.
20. Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y. The Patient Health Questionnaire (PHQ)-9: a depression diagnostic and severity measure in primary care. Jpn J Psychiatr Treat. 2008;23:1299-1306.
21. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series. 2000;894:1-253.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.